NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
+48.34%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
Cap. Flow
-$3.99M
Cap. Flow %
-2.49%
Top 10 Hldgs %
82.84%
Holding
41
New
2
Increased
4
Reduced
1
Closed
2

Top Buys

1
MIRM icon
Mirum Pharmaceuticals
MIRM
$2.84M
2
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$1.56M
3
PACB icon
Pacific Biosciences
PACB
$1.35M
4
KALV icon
KalVista Pharmaceuticals
KALV
$854K
5
GERN icon
Geron
GERN
$338K

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$9.99M
2
OCS icon
Oculis Holding
OCS
$985K
3
AKRO icon
Akero Therapeutics
AKRO
$224K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$71.4M 44.49% 225,688 – –
ILMN icon
2
Illumina
ILMN
$15.8B
$16.6M 10.34% 119,196 – –
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$11.9M 7.42% 368,665 – –
OCS icon
4
Oculis Holding
OCS
$844M
$5.83M 3.63% 518,933 -87,751 -14% -$985K
EXAI
5
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$5.51M 3.43% 859,892 – –
ALPN
6
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$5.03M 3.13% 263,940 +81,660 +45% +$1.56M
XENE icon
7
Xenon Pharmaceuticals
XENE
$2.98B
$4.91M 3.06% 106,680 – –
SLGC
8
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.29M 2.67% 1,696,558 – –
MRUS icon
9
Merus
MRUS
$4.98B
$3.77M 2.35% 137,038 – –
KALV icon
10
KalVista Pharmaceuticals
KALV
$678M
$3.73M 2.32% 304,277 +69,704 +30% +$854K
MIRM icon
11
Mirum Pharmaceuticals
MIRM
$3.71B
$2.84M 1.77% +96,100 New +$2.84M
PACB icon
12
Pacific Biosciences
PACB
$393M
$2.69M 1.68% 274,488 +137,833 +101% +$1.35M
ONC
13
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$2.17M 1.35% 12,022 – –
INCY icon
14
Incyte
INCY
$16.5B
$2.01M 1.25% 32,022 – –
GERN icon
15
Geron
GERN
$893M
$1.93M 1.2% 913,550 +160,000 +21% +$338K
RYTM icon
16
Rhythm Pharmaceuticals
RYTM
$6.85B
$1.84M 1.15% 40,070 – –
RANI icon
17
Rani Therapeutics
RANI
$24.4M
$1.64M 1.02% 493,584 – –
REPL icon
18
Replimune Group
REPL
$422M
$1.56M 0.97% 184,739 – –
EXEL icon
19
Exelixis
EXEL
$10.1B
$1.54M 0.96% 64,200 – –
BOLT icon
20
Bolt Biotherapeutics
BOLT
$9.85M
$1.31M 0.81% 1,166,952 – –
JBIO
21
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$1.08M 0.68% 47,936 – –
CABA icon
22
Cabaletta Bio
CABA
$133M
$1.07M 0.67% 47,150 – –
ACAD icon
23
Acadia Pharmaceuticals
ACAD
$4.38B
$939K 0.58% 29,984 – –
TRDA icon
24
Entrada Therapeutics
TRDA
$208M
$741K 0.46% 49,082 – –
ALXO icon
25
ALX Oncology
ALXO
$62.7M
$625K 0.39% 41,950 – –
1
2